ArticleEuropean journal of medical research2025

Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy.

Xuehan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.